Neochromosome Inc
City-funded organization
Neochromosome Inc is a Long Island City synthetic-biology company (a wholly owned subsidiary of Opentrons Labworks) spun out of NYU's Boeke lab synthetic-yeast research; it holds one negotiated Department of Health and Mental Hygiene contract worth $56.9 million for whole-genome sequencing of SARS-CoV-2 variants through FY2029.
- Industry (per city contracts)
- Human Services
- City contracts (active)
- $56,904,000 · 1 contract
- Awarded all-time
- $56,904,000 · 1 since 2023, incl. expired
- Paid to date
- $2,416,725
- Won without a fresh bid
- 100% of contract value · $56,904,000 · 1 contract
Holds contracts at
- Department of Health and Mental Hygiene City agency
City contracts
Registered city contracts, largest first by current contract value (not amount spent): running now, then registered to start later, then ended. Totals count every registered contract. Each line shows its Checkbook contract ID. The tag on each row is how it was awarded (“no-bid” = non-competitive).
- Whole Genome Sequencing for SARS-CoV-2 variants for FY23-29. Department of Health and Mental Hygiene · CT181620248802120 $56,904,000
Federal awards
Federal awards made directly to this organization in fiscal years 2023 through 2026. Each amount is what the federal government has OBLIGATED on that award as recorded on USAspending.gov as of 2026-08-31 — money committed, not money paid out. These are prime awards only: federal money this
- Department of Health and Human Services 93.855 Allergy and Infectious Diseases Research · National Institutes of Health · Grant $600,000
- Department of Health and Human Services 93.350 National Center for Advancing Translational Sciences · National Institutes of Health · Grant $323,408